Klarquist Sparkman, LLP
Method of reducing inflammatory infiltration in subjects with inflammatory lung disease
The present disclosure relates to oligodeoxynucleotides that suppress an immune response. Methods are disclosed for reducing neutrophil infiltration in subjects with inflammatory lung disease-by administering a therapeutically effective amount of a suppressive oligodeoxynucleotide.
The United States of America as Represented by the Secretary of the Department of Health and Human Services
A C A A A A C
A61P C12N A61P A61P A61P A61P C12N
inventional inventional inventional inventional inventional inventional additional
Dennis M. Hiroshi
Klinman Yamada